Centers for Disease Control and Prevention, 23979 [2014-09701]

Download as PDF Federal Register / Vol. 79, No. 82 / Tuesday, April 29, 2014 / Notices appointed as public members of federal advisory committees. Individuals appointed to serve as public members of federal advisory committees are classified as special government employees (SGEs). SGEs are government employees for purposes of the conflict of interest laws. Therefore, individuals appointed to serve as public members of NVAC are subject to an ethics review. The ethics review is conducted to determine if the individual has any interests and/or activities in the private sector that may conflict with performance of their official duties as a member of the NVAC. Individuals appointed to serve as public members of the NVAC will be required to disclose information regarding financial holdings, consultancies, research grants and/or contracts, and the absence of an appearance of a loss of impartiality. Dated: April 22, 2014. Bruce Gellin, Deputy Assistant Secretary for Health, Director, National Vaccine Program Office, Executive Secretary, National Vaccine Advisory Committee. [FR Doc. 2014–09634 Filed 4–28–14; 8:45 am] BILLING CODE 4150–44–P sroberts on DSK5SPTVN1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Evaluating Promising Strategies to Build the Evidence Base for Sexual Violence Prevention, Funding Opportunity Announcement (FOA) CE14–005, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 10:30 a.m.–7:30 p.m. EDT, May 15, 2014 (Closed) Place: CDC, 4770 Buford Highway, Conference Room 8C, Atlanta, Georgia 30341 Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters For Discussion: The meeting will include the initial review, discussion, and evaluation of 16:56 Apr 28, 2014 [FR Doc. 2014–09703 Filed 4–28–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Centers for Disease Control and Prevention Jkt 232001 Review Officer, CDC, 4770 Buford Highway, NE., Mailstop F63, Atlanta, Georgia 30341, Telephone: (770) 488– 0641. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Gary J. Johnson, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–09701 Filed 4–28–14; 8:45 am] BILLING CODE 4163–18–P Gary J. Johnson, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Mar<15>2010 applications received in response to ‘‘Evaluating Promising Strategies to Build the Evidence Base for Sexual Violence Prevention, FOA CE14–005.’’ Contact Person For More Information: Donald Blackman, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341, Telephone: (770) 488– 0641. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. 23979 The meeting announced below concerns Research Grants for Preventing Violence and Violence Related Injury, Funding Opportunity Announcement (FOA) CE14–006, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 10:30 a.m.–5:30 p.m. EDT, May 29–30, 2014 (Closed) Place: CDC, 4770 Buford Highway, Conference Rooms 8C and 8A, Atlanta, Georgia 30341 Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters For Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Research Grants for Preventing Violence and Violence Related Injury, FOA CE14–006.’’ Contact Person For More Information: Donald Blackman, Ph.D., Scientific PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ ATSDR) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 9:15 a.m.–4:15 p.m., May 22, 2014; 8:30 a.m.–12:30 p.m., May 23, 2014. Place: CDC, 4770 Buford Highway, Atlanta, Georgia 30341. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 60 people. Purpose: The Secretary, Department of Health and Human Services (HHS) and by delegation, the Director, CDC and Administrator, NCEH/ATSDR, are authorized under Section 301 (42 U.S.C. 241) and Section 311 (42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1) Conduct, encourage, cooperate with, and assist other appropriate public authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases and other impairments; (2) assist states and their political subdivisions in the prevention of infectious diseases and other preventable conditions and in the promotion of health and well being; and E:\FR\FM\29APN1.SGM 29APN1

Agencies

[Federal Register Volume 79, Number 82 (Tuesday, April 29, 2014)]
[Notices]
[Page 23979]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09701]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Centers for Disease Control and Prevention

Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Research Grants for Preventing 
Violence and Violence Related Injury, Funding Opportunity Announcement 
(FOA) CE14-006, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time and Date: 10:30 a.m.-5:30 p.m. EDT, May 29-30, 2014 (Closed)
    Place: CDC, 4770 Buford Highway, Conference Rooms 8C and 8A, 
Atlanta, Georgia 30341
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters For Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Research Grants for Preventing Violence and Violence Related 
Injury, FOA CE14-006.''
    Contact Person For More Information: Donald Blackman, Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop F63, 
Atlanta, Georgia 30341, Telephone: (770) 488-0641.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Gary J. Johnson,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2014-09701 Filed 4-28-14; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.